首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Characterization of 3H-(2S2′R3′R)-2-(2′3′-dicarboxy- cyclopropyl)glycine (3H-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes
【2h】

Characterization of 3H-(2S2′R3′R)-2-(2′3′-dicarboxy- cyclopropyl)glycine (3H-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes

机译:3H-(2S2R3R)-2-(23-二羧基-环丙基)甘氨酸(3H -DCG IV)与代谢型mGlu2受体转染的细胞膜结合的表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">The binding of the new selective group II metabotropic glutamate receptor radioligand, [3H]-(2>S,2′>R,3′>R)-2-(2′,3′-dicarboxycyclopropyl)glycine ([3H]-DCG IV), was characterized in rat mGlu2 receptor-transfected CHO cell membranes.[3H]-DCG IV binding was pH-dependent, but was not sensitive to temperature. Saturation analysis showed the presence of a single binding site, with a Kd value of 160 nM and a Bmax value of 10 pmol mg−1 protein. Binding was not sensitive to Na+-dependent glutamate uptake blockers or Cl-dependent glutamate binding inhibitors. Furthermore, up to concentrations of 1 mM, the glutamate ionotropic receptor agonists, N-methyl-D-aspartic acid (NMDA), (>S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate, did not affect [3H]-DCG IV binding.Of the compounds observed to inhibit [3H]-DCG IV binding, the most potent were the recently described selective group II agonist, (+)-2-aminobicyclo-[3.1.0]hexane-2,6-dicarboxylate (LY 354740; Ki value 16 nM) and antagonist, 2-amino-2-(2-carboxycyclopropan-1-yl)-3-(dibenzopyran-4-yl) propanoic acid (LY 341495; Ki value 19 nM). As expected, for a G-protein-coupled receptor, guanosine-5′-O-(3-thiotriphosphate) (GTPγS) inhibited [3H]-DCG IV binding in a concentration-dependent manner, with an IC50 value of 12 nM.A highly significant correlation was observed between the potencies of compounds able to inhibit [3H]-DCG IV binding and potencies obtained for agonist activity in a GTPγ35S binding functional assay. In addition, these studies identified a number of compounds with previously unknown activity at mGlu2 receptors, including L(+)-2-amino-3-phosphonopropionic acid (L-AP3), L(+)-2-amino-5-phosphonopentanoic acid (L-AP5), 3-((>RS)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (>R-CPP), N-acetyl-L-aspartyl-L-glutamic acid (NAAG) and (>RS)-α-methylserine-O-phosphate (MSOP).
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 新的选择性第二组代谢型谷氨酸受体放射性配体[ 3 H]-(2 > S ,2'> R ,3'<在大鼠mGlu2受体转染的CHO细胞膜中表征了强> R )-2-(2',3'-二羧基环丙基)甘氨酸([ 3 H] -DCG IV)。 [ 3 H] -DCG IV结合具有pH依赖性,但对温度不敏感。饱和分析显示存在单个结合位点,Kd值为160 nM,Bmax值为10 pmol mg -1 蛋白。结合对依赖于Na + 的谷氨酸摄取阻滞剂或依赖于Cl -的谷氨酸结合抑制剂不敏感。此外,谷氨酸离子受体激动剂,N-甲基-D-天冬氨酸(NMDA),(> S )-α-氨基-3-羟基-5-甲基- 4-异恶唑丙酸(AMPA)和海藻酸盐不影响[ 3 H] -DCG IV的结合。 在这些化合物中,抑制[ 3 H] -DCG IV结合,最有效的是最近描述的选择性II组激动剂,(+)-2-氨基双环-[3.1.0]己烷-2,6-二羧酸酯(LY 354740; Ki值为16 nM)和拮抗剂,2-氨基-2-(2-羧基环丙烷-1-基)-3-(二苯并吡喃-4-基)丙酸(LY 341495; Ki值为19 nM)。不出所料,对于G蛋白偶联受体,鸟苷5'-O-(3-硫代三磷酸)(GTPγS)以浓度依赖的方式抑制[ 3 H] -DCG IV结合, IC50值为12 nM。 在能够抑制[ 3 H] -DCG IV结合的化合物的效力与激动剂活性获得的效力之间观察到高度相关性在GTPγ 35 S结合功能试验中此外,这些研究还发现了许多对mGlu2受体具有未知活性的化合物,包括L(+)-2-氨基-3-膦酸丙酸(L-AP3),L(+)-2-氨基-5-膦基戊酸酸(L-AP5),3-((> RS )-2-羧基哌嗪-4-基)-丙基-1-膦酸(> R -CPP),N -乙酰基-L-天冬氨酰-L-谷氨酸(NAAG)和(> RS )-α-甲基丝氨酸-O-磷酸(MSOP)。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号